Prof. Christoph A. Nienaber new member of Medical Advisory Board of PHTS Telemedizin

SHL TeleMedicine Ltd.PHTS Telemedizin, the wholly owned German subsidiary of SHL Telemedicine Ltd. (SWX:SHLTN), has appointed Prof. Dr. med. Christoph A. Nienaber to its Medical Advisory Board. The renowned cardiologist strengthens PHTS Telemedizin with his cardiological competence and profound know-how in the implementation of telemedicine.

Prof. Nienaber holds the chair of cardiology at the University of Rostock and has been the head of the cardiological clinic for the last seven years. He has been a leading figure for several years in the structuring of telemedicine support programmes within the framework of integrated care and is recognized as one of the pioneers in the field. He is already working closely with PHTS Telemedizin. "Coronary heart diseases are a core field for the application of telemedicine and I am looking forward to using my experience to support the colleagues at PHTS Telemedizin with advice and action."

Personal HealthCare Telemedicine Services GmbH (PHTS), established in Düsseldorf in 2001, is a wholly owned subsidiary of SHL Telemedicine. PHTS Telemedizin (www.phts.de) combines innovative telemedicine solutions which have been proven in practice with well-founded medical-technical know-how. PHTS (www.phts.de) therefore holds a leading position throughout Germany in the field of cardiological telemedicine.

Related news article:

About SHL TeleMedicine
SHL TeleMedicine Ltd. is a leading provider and developer of advanced personal telemedicine solutions to individuals and to the healthcare community. As a provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in the US, Europe and Israel. SHL is listed on the SWX Swiss Exchange, symbol SHLTN. For more information see www.shl-telemedicine.com.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...